Archive for 2001

Benchmarks articles from the selected year appear below. To view articles from previous years, use the links to the left, and select the year you wish to see.

Details of the Immunotoxin Trial

Moving immunotoxins from bench to bedside

Objectives

I. Assess the therapeutic efficacy and toxicity of the recombinant immunotoxin LMB-2, an anti-Tac murine monoclonal antibody fragment conjugated to a truncated portion of Pseudomonas exotoxin, in patients with Tac-expressing leukemias and lymphomas.